Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 19125679)

Published in Infect Control Hosp Epidemiol on February 01, 2009

Authors

Andrew M Ramsey1, Marya D Zilberberg

Author Affiliations

1: School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts, USA.

Articles citing this

The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol (2012) 4.64

Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22

Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J (2011) 1.33

Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis (2014) 1.04

Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother (2013) 1.02

VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol (2015) 1.01

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med (2010) 1.00

Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections. Antimicrob Agents Chemother (2015) 1.00

Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS One (2013) 1.00

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol (2012) 0.99

Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis (2015) 0.94

Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections. Clin Infect Dis (2016) 0.90

High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland. Eur J Clin Microbiol Infect Dis (2013) 0.88

Endophthalmitis caused by Enterococcus faecalis: clinical features, antibiotic sensitivities, and outcomes. Am J Ophthalmol (2014) 0.85

Modeling the regional spread and control of vancomycin-resistant enterococci. Am J Infect Control (2013) 0.84

Controlling a vancomycin-resistant enterococci outbreak in a Brazilian teaching hospital. Eur J Clin Microbiol Infect Dis (2010) 0.82

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leuk Lymphoma (2014) 0.82

Changes in enterococcal populations and related antibiotic resistance along a medical center-wastewater treatment plant-river continuum. Appl Environ Microbiol (2013) 0.81

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013). Antimicrob Agents Chemother (2015) 0.81

Evolutionary dynamics of Enterococcus faecium reveals complex genomic relationships between isolates with independent emergence of vancomycin resistance. Microb Genom (2016) 0.80

Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: a short case series. BMC Urol (2013) 0.77

Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid. Infect Dis Clin Pract (Baltim Md) (2017) 0.75

Vancomycin-Variable Enterococcal Bacteremia. J Clin Microbiol (2015) 0.75

Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital. Infect Chemother (2014) 0.75

Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrob Agents Chemother (2017) 0.75

A Novel Way of Treating Multidrug-resistant Enterococci. N Am J Med Sci (2016) 0.75

Emergence of Vancomycin-resistant Enterococci at a Teaching Hospital, Saudi Arabia. Chin Med J (Engl) (2017) 0.75

Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections. J Glob Antimicrob Resist (2015) 0.75

Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis. Open Forum Infect Dis (2016) 0.75

Articles by these authors

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46

Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83

Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61

Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60

Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58

Growth in dementia-associated hospitalizations among the oldest old in the United States: implications for ethical health services planning. Arch Intern Med (2011) 1.46

Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis (2009) 1.39

Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25

Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07

Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis (2008) 1.05

Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2009) 0.99

Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc (2006) 0.88

Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin (2008) 0.86

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis (2014) 0.86

Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol (2013) 0.85

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis (2014) 0.83

Outcomes and charges of elderly patients with acute myeloid leukemia. Am J Hematol (2006) 0.80

Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients? Infect Control Hosp Epidemiol (2014) 0.79

Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79

Preferences in traumatic intracranial hemorrhage: bleeding vs. clotting. Crit Care (2010) 0.78

The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy. Curr Med Res Opin (2007) 0.77

Diagnostics and epidemiology in ventilator-associated pneumonia. Ther Adv Respir Dis (2011) 0.77

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study. BMJ Open (2013) 0.77

Severe acute hypertension among inpatients admitted from the emergency department. J Hosp Med (2011) 0.77

Bacteremia increases the risk of death among patients with soft-tissue infections. Surg Infect (Larchmt) (2010) 0.76

Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia. Curr Med Res Opin (2007) 0.76

Admitting What We Do Not Know About Pneumonia Readmissions. Chest (2015) 0.75

The swan song of the pulmonary artery catheter. Crit Care Med (2013) 0.75

Case mix as the determinant of outcomes: the devil is in the details. Crit Care Med (2008) 0.75

Translational highway: it helps to have a map. Crit Care Med (2007) 0.75

Bayesian thinking: a safer tool for reassurance. Arch Intern Med (2011) 0.75

Population health issue in critical care: expanding our focus beyond the intensive care unit. Crit Care Med (2012) 0.75

Surviving sepsis: a time for "don't just do something, stand there" philosophy? Crit Care Med (2012) 0.75

What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? Ann Intern Med (2008) 0.75

Nature (and the ICU) abhors a VACuum. Chest (2012) 0.75

Risk-benefit decision making in traumatic brain injury: Ratios, realities, results. J Emerg Trauma Shock (2012) 0.75

Prolonged mechanical ventilation: pushing the limits of magic in medicine? Crit Care Med (2009) 0.75

Customer satisfaction: coming to an intensive care unit near you! Crit Care Med (2012) 0.75

Endometriosis and ovarian cancer. Lancet Oncol (2012) 0.75

Ventilator-associated pneumonia: we cannot wish it away*. Crit Care Med (2014) 0.75

Augmented renal clearance: an augmented definition of appropriate antibiotic therapy?*. Crit Care Med (2014) 0.75

Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a concept. Curr Opin Pulm Med (2015) 0.75

Growth in the incidence of hospitalizations with resistant infections in elderly people in the United States: 2000 to 2006. J Am Geriatr Soc (2008) 0.75